ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 151

$1.87M Total Retail Price of All Prescriptions

Rank: 3 out of 151

1,090 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,090 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 1,090 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,699 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 848 691 1 4
FUROSEMIDE 580 526 2 6
LISINOPRIL 538 431 3 5
SIMVASTATIN 519 485 4 1
DIOVAN 512 456 5 33
METOPROLOL TARTRATE 507 422 6 7
CRESTOR 488 401 7 27
AMLODIPINE BESYLATE 428 395 8 3
NEXIUM 410 353 9 44
LEVOTHYROXINE SODIUM 399 382 10 2
CARVEDILOL 377 351 11 22
IBUPROFEN 373 309 12 69
CLOPIDOGREL 349 299 13 29
POTASSIUM CHLORIDE 347 325 14 19
GABAPENTIN 333 289 15 14
METFORMIN HCL 290 269 16 8
ATENOLOL 289 278 17 11
PLAVIX 288 261 18 37
LIDODERM 275 224 19 65
PANTOPRAZOLE SODIUM 270 236 20 34
WARFARIN SODIUM 247 231 21 9
RANITIDINE HCL 242 204 22 32
ZOLPIDEM TARTRATE 234 192 23 17
NAMENDA 229 225 24 20
LOVAZA 224 185 25 125
ESCITALOPRAM OXALATE 221 203 26 40
DONEPEZIL HCL 220 213 27 15
TAMSULOSIN HCL 215 196 28 30
ADVAIR DISKUS 212 177 29 46
METOPROLOL SUCCINATE 211 182 30 21
DIGOXIN 210 207 31 39
VOLTAREN 210 179 31 116
DIOVAN HCT 192 184 33 92
CLOTRIMAZOLE-BETAMETHASONE 188 163 34 100
AZITHROMYCIN 181 145 35 36
MECLIZINE HCL 181 148 35 86
LEVOFLOXACIN 173 147 37 80
LANTUS 164 136 38 47
LYRICA 158 106 39 120
SINGULAIR 156 152 40 72
CELEBREX 154 137 41 110
INSULIN SYRINGE 147 105 42 96
ATORVASTATIN CALCIUM 146 115 43 16
LACTULOSE 144 122 44 101
EXELON 142 131 45 63
NOVOLOG MIX 70-30 141 124 46 196
ISOSORBIDE MONONITRATE ER 141 140 46 55
TEMAZEPAM 138 117 48 49
BUMETANIDE 135 123 49 158
PREDNISONE 135 129 49 45
MEGESTROL ACETATE 135 132 R 49 148
ALPRAZOLAM 124 110 52 41
NOVOLOG 123 98 53 76
CITALOPRAM HBR 123 109 53 18
GLIPIZIDE 118 112 55 43
CLONIDINE HCL 118 91 55 52
HYDROCHLOROTHIAZIDE 116 109 57 13
PAROXETINE HCL 113 108 58 54
CYMBALTA 109 80 59 62
LOSARTAN POTASSIUM 108 103 60 12
SYNTHROID 107 101 61 60
CILOSTAZOL 104 100 62 211
QUETIAPINE FUMARATE 101 85 63 53
GLYBURIDE-METFORMIN HCL 101 72 R 63 107
SERTRALINE HCL 101 88 63 25
GLYBURIDE 98 88 R 66 75
HEPARIN SODIUM 97 62 67 195
TRAMADOL HCL 96 91 68 24
METOCLOPRAMIDE HCL 94 85 69 139
FOLIC ACID 93 80 70 140
PEN NEEDLE 93 70 70 186
ALENDRONATE SODIUM 93 92 70 26
OXYCODONE-ACETAMINOPHEN 92 70 S2 73 66
CYCLOBENZAPRINE HCL 92 50 R 73 126
NASONEX 89 76 75 260
MONTELUKAST SODIUM 86 78 76 120
RISPERIDONE 84 72 77 50
MUPIROCIN 83 71 78 130
IPRATROPIUM BROMIDE 83 76 78 132
FINASTERIDE 83 83 78 70
FAMOTIDINE 82 82 81 64
LEXAPRO 82 73 81 105
NOVOLIN 70-30 82 82 81 158
ABILIFY 82 65 81 135
NITROGLYCERIN PATCH 81 81 85 153
CARBIDOPA-LEVODOPA 80 70 86 82
ALLOPURINOL 79 54 87 42
LANSOPRAZOLE 79 52 87 118
MIRTAZAPINE 78 67 89 28
NOVOLOG MIX 70-30 FLEXPEN 75 70 90 295
ALBUTEROL SULFATE 74 72 91 102
DILTIAZEM 24HR CD 74 74 91 136
NAPROXEN 74 60 91 93
NITROSTAT 74 71 91 242
AMLODIPINE BESYLATE-BENAZEPRIL 73 70 95 89
ACTOS 71 58 96 178
PROCTOZONE-HC 71 68 96 221
KLOR-CON 10 70 62 98 95
METRONIDAZOLE 70 61 98 302
DICLOFENAC SODIUM 67 54 100 109
PROAIR HFA 66 53 101 71
DICYCLOMINE HCL 65 51 102 309
CIPROFLOXACIN HCL 65 59 102 51
EXFORGE 64 64 104 314
AMIODARONE HCL 63 61 105 181
COMBIVENT 61 25 106 161
GLIMEPIRIDE 61 60 106 58
LANTUS SOLOSTAR 60 43 108 133
AMOX TR-POTASSIUM CLAVULANATE 60 51 108 115
AGGRENOX 60 50 108 204
NIFEDIPINE ER 60 58 108 83
PENTOXIFYLLINE 58 58 112 191
BACLOFEN 57 17 113 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 34 114 128
ENALAPRIL MALEATE 56 50 114 38
TRAZODONE HCL 55 45 116 48
LEVETIRACETAM 55 28 116 85
PHENYTOIN SODIUM EXTENDED 54 51 118 160
DEXILANT 54 54 118 257
GEMFIBROZIL 53 43 120 104
SEROQUEL 53 37 120 113
BENAZEPRIL HCL 53 40 120 103
CLOTRIMAZOLE 50 47 123 278
ENOXAPARIN SODIUM 50 39 123 228
HYDROCODONE-ACETAMINOPHEN 50 21 S3 123 10
ACETAMINOPHEN-CODEINE 50 45 S3 123 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.